期刊文献+

Placental-derived stem cells:Culture, differentiation and challenges 被引量:10

Placental-derived stem cells:Culture, differentiation and challenges
下载PDF
导出
摘要 Stem cell therapy is a promising approach to clinical healing in several diseases. A great variety of tissues(bone marrow, adipose tissue, and placenta) arepotentially sources of stem cells. Placenta-derived stem cells(p-SCs) are in between embryonic and mesenchymal stem cells, sharing characteristics with both, such as non-carcinogenic status and property to differentiate in all embryonic germ layers. Moreover, their use is not ethically restricted as fetal membranes are considered medical waste after birth. In this context, the present review will be focused on the biological properties, culture and potential cell therapy uses of placental-derived stem cells. Immunophenotype characterization, mainly for surface marker expression, and basic principles of p-SC isolation and culture(mechanical separation or enzymatic digestion of the tissues, the most used culture media, cell plating conditions) will be presented. In addition, some preclinical studies that were performed in different medical areas will be cited, focusing on neurological, liver, pancreatic, heart, muscle, pulmonary, and bone diseases and also in tissue engineering field. Finally, some challenges for stem cell therapy applications will be highlighted. The understanding of the mechanisms involved in the p-SCs differentiation and the achievement of pure cell populations(after differentiation) are key points that must be clarified before bringing the preclinical studies, performed at the bench, to the medical practice. Stem cell therapy is a promising approach to clinicalhealing in several diseases. A great variety of tissues(bone marrow, adipose tissue, and placenta) arepotentially sources of stem cells. Placenta-derivedstem cells (p-SCs) are in between embryonic andmesenchymal stem cells, sharing characteristics withboth, such as non-carcinogenic status and property todifferentiate in all embryonic germ layers. Moreover,their use is not ethically restricted as fetal membranesare considered medical waste after birth. In this context,the present review will be focused on the biologicalproperties, culture and potential cell therapy usesof placental-derived stem cells. Immunophenotypecharacterization, mainly for surface marker expression,and basic principles of p-SC isolation and culture(mechanical separation or enzymatic digestion ofthe tissues, the most used culture media, cell platingconditions) will be presented. In addition, somepreclinical studies that were performed in differentmedical areas will be cited, focusing on neurological,liver, pancreatic, heart, muscle, pulmonary, and bonediseases and also in tissue engineering field. Finally,some challenges for stem cell therapy applications willbe highlighted. The understanding of the mechanismsinvolved in the p-SCs differentiation and the achievementof pure cell populations (after differentiation) arekey points that must be clarified before bringing thepreclinical studies, performed at the bench, to themedical practice.
出处 《World Journal of Stem Cells》 SCIE CAS 2015年第4期769-775,共7页 世界干细胞杂志(英文版)(电子版)
基金 Supported by Coordenacao de Aperfeicoamento de Pessoal de Nível Superior(CAPES) Conselho Nacional de Desenvolvmento Científico e Tecnológico(CNPq) Fundacao de AmparoàPesquisa do estado de Minas Gerais(FAPEMIG)
关键词 FETAL membrane PLACENTA EMBRYONIC STEMCELLS MESENCHYMAL stem cells Cell therapy Fetal membrane Placenta Embryonic stem cells Mesenchymal stem cells Cell therapy
  • 相关文献

参考文献54

  • 1Titomanlio L, Kavelaars A, Dalous J, Mani S, El Ghouzzi V,Heijnen C, Baud O, Gressens P. Stem cell therapy for neonatal braininjury: perspectives and challenges. Ann Neurol 2011; 70: 698-712[PMID: 22162055 DOI: 10.1002/ana.22518].
  • 2Barboni B, Mangano C, Valbonetti L, Marruchella G, BerardinelliP, Martelli A, Muttini A, Mauro A, Bedini R, Turriani M, PecciR, Nardinocchi D, Zizzari VL, Tetè S, Piattelli A, Mattioli M.Synthetic bone substitute engineered with amniotic epithelial cellsenhances bone regeneration after maxillary sinus augmentation.PLoS One 2013; 8: e63256 [PMID: 23696804 DOI: 10.1371/journal.pone.0063256].
  • 3Ventura C, Cantoni S, Bianchi F, Lionetti V, Cavallini C, ScarlataI, Foroni L, Maioli M, Bonsi L, Alviano F, Fossati V, Bagnara GP,Pasquinelli G, Recchia FA, Perbellini A. Hyaluronan mixed estersof butyric and retinoic Acid drive cardiac and endothelial fate interm placenta human mesenchymal stem cells and enhance cardiacrepair in infarcted rat hearts. J Biol Chem 2007; 282: 14243-14252[PMID: 17363374 DOI: 10.1074/jbc.M609350200].
  • 4Solter D. From teratocarcinomas to embryonic stem cells andbeyond: a history of embryonic stem cell research. Nat Rev Genet2006; 7: 319-327 [PMID: 16534514 DOI: 10.1038/nrg1827].
  • 5Chamberlain G, Fox J, Ashton B, Middleton J. Concise review:mesenchymal stem cells: their phenotype, differentiation capacity,immunological features, and potential for homing. Stem Cells 2007;25: 2739-2749 [PMID: 17656645 DOI: 10.1634/stemcells.2007-0197].
  • 6Wulf GG, Viereck V, Hemmerlein B, Haase D, Vehmeyer K,Pukrop T, Glass B, Emons G, Trümper L. Mesengenic progenitorcells derived from human placenta. Tissue Eng 2004; 10: 1136-1147[PMID: 15363170].
  • 7Wolbank S, van Griensven M, Grillari-Voglauer R, Peterbauer-Scherb A. Alternative sources of adult stem cells: human amnioticmembrane. Adv Biochem Eng Biotechnol 2010; 123: 1-27 [PMID:20237903].
  • 8Rus Ciuc D, Soriu O, Suman S, Pop VI, Mihu CM. Isolationand characterization of chorionic mesenchyal stem cells from theplacenta. Rom J Morphol Embryol 2011; 52: 803-808 [PMID:21892522].
  • 9Karlsson H, Erkers T, Nava S, Ruhm S, Westgren M, Ringdén O.Stromal cells from term fetal membrane are highly suppressive inallogeneic settings in vitro. Clin Exp Immunol 2012; 167: 543-555[PMID: 22288598 DOI: 10.1111/j.1365-2249.2011.04540.x].
  • 10Miao Z, Jin J, Chen L, Zhu J, Huang W, Zhao J, Qian H, ZhangX. Isolation of mesenchymal stem cells from human placenta:comparison with human bone marrow mesenchymal stem cells.Cell Biol Int 2006; 30: 681-687 [PMID: 16870478].

同被引文献27

引证文献10

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部